Our Expertise
Advanced Wound Care Solutions
SR Pharma (Sanitas Renova) is committed to providing innovative, high-quality wound care solutions to the Saudi market. Our wound care portfolio ranges from advanced hydrogels and silicone-based products to specialized dressings, each carefully selected to meet SFDA medical device standards. Whether dealing with burns, surgical wounds, or chronic ulcers, our products help ensure optimal healing and patient comfort.
Local Manufacturing Capabilities
In line with our goal of localizing production, SR Pharma (Sanitas Renova) is developing manufacturing capabilities in Saudi Arabia. By bringing in Active Pharmaceutical Ingredients (APIs) and establishing production lines that meet SFDA requirements, we ensure consistent access to pharmaceutical-grade products while reducing reliance on imports. This initiative underlines our commitment to self-sufficiency and to the overall growth of the Kingdom’s healthcare sector.
Saudi Market Leadership
Our deep understanding of local healthcare dynamics, bolstered by strategic partnerships with Key Opinion Leaders (KOLs), positions SR Pharma (Sanitas Renova) as a trusted partner in elevating healthcare standards across Saudi Arabia. Through these collaborations, we remain at the forefront of industry trends and best practices.
Specialized Healthcare Products (Future Expansion)
Looking ahead, SR Pharma (Sanitas Renova) plans to broaden our product portfolio to target additional therapeutic areas. By continually seeking innovative, high-quality solutions, we aim to improve patient outcomes and drive sustainable growth in the Kingdom’s healthcare landscape.
Why SR Pharma (Sanitas Renova)?
- Proven Expertise: Over 30 years of combined experience in wound care and therapeutic innovation, highlighted by the success of MEBO under the leadership of our founders.
- Comprehensive Business Model: A versatile approach combining private labeling, local manufacturing, and agency representation for maximum market impact.
- Localized Manufacturing: Committed to producing high-quality pharmaceuticals within Saudi Arabia, reducing reliance on imports and supporting Vision 30 goals.
- Advanced Wound Care Solutions: Expanding a portfolio of innovative wound care products, including hydrogels, silicone-based solutions, and advanced dressings aligned with SFDA standards.
- Forward-Thinking Strategy: A clear focus on diversifying into specialized healthcare solutions to address evolving market needs.
- Trusted Partnerships: Strong collaborations with healthcare providers, global manufacturers, and regulators to ensure excellence in patient care and market success.
Future Outlook
SR Pharma (Sanitas Renova) aims to build a future where Advanced Wound Care Solutions anchor its portfolio while expanding into specialized healthcare solutions that meet evolving patient needs.
Through investments in local manufacturing and the establishment of production facilities within Saudi Arabia, SR Pharma (Sanitas Renova) is dedicated to fostering a sustainable healthcare ecosystem in alignment with Saudi Vision 2030.
Let’s Shape the Future of Healthcare Together
Partner with SR Pharma (Sanitas Renova) to drive innovation, localize manufacturing, and deliver patient-centered healthcare solutions in Saudi Arabia.
Together, we can achieve sustainable growth, transform care delivery, and contribute to the realization of Saudi Vision 2030. Join us in redefining excellence—start your journey with SR Pharma (Sanitas Renova) today.
Copyrights © 2025 Sanitas Renova.